XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations (unaudited) - USD ($)
 3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
REVENUES    
Product revenue, net $ 0 $ 2,105,977
OPERATING EXPENSES    
Research and development 5,743,754 5,014,630
Selling, general and administrative 2,020,931 3,200,244
Total operating expenses 7,764,685 8,214,874
Loss from operations (7,764,685) (6,108,897)
OTHER (EXPENSE) INCOME    
Investment income 78,576 71,630
Foreign currency transaction (loss) gain (131,600) 159,750
Interest expense (5,940) (10,882)
Change in fair value of warrant liabilities 0 682,400
Total other (expense) income, net (58,964) 902,898
NET LOSS $ (7,823,649) $ (5,205,999)
Basic and diluted net loss per common share $ (0.39) $ (0.43)
Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share 19,845,106 12,170,699